Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TSE
701
DELISTED
Trinseo
TSE
| $34.9M | 0.03% |
936,600
-85,800
| -8% | -$3.49M |
|
|
CRCM
702
DELISTED
CARE.COM, INC.
CRCM
| $34.8M | 0.03% |
2,313,700
-120,400
| -5% | -$1.45M |
|
703
Roper Technologies
ROP
$39.3B
| $34.8M | 0.03% |
98,102
+51,202
| +109% | +$17.7M |
|
|
CWEN.A
704
DELISTED
Clearway Energy Class A
CWEN.A
| $34.5M | 0.03% |
1,804,030
+177,000
| +11% | +$3.26M |
|
705
Middlesex Water
MSEX
$1.11B
| $34.5M | 0.03% |
542,100
-25,200
| -4% | -$1.6M |
|
706
American Public Education
APEI
$828M
| $34.4M | 0.03% |
1,255,893
-17,800
| -1% | -$435K |
|
707
Extreme Networks
EXTR
$3.16B
| $34.3M | 0.03% |
4,652,231
+374,983
| +9% | +$2.63M |
|
708
Towne Bank
TOWN
$3.5B
| $34.3M | 0.03% |
1,231,742
+54,800
| +5% | +$1.54M |
|
709
Pricesmart
PSMT
$5.55B
| $34.2M | 0.03% |
482,000
-149,500
| -24% | -$10.7M |
|
710
PennyMac Financial
PFSI
$4.13B
| $34.2M | 0.03% |
1,003,693
+421,693
| +72% | +$13.7M |
|
711
Qualys
QLYS
$6.78B
| $34.1M | 0.03% |
409,400
-43,500
| -10% | -$3.61M |
|
|
ADSW
712
DELISTED
Advanced Disposal Services Inc
ADSW
| $34.1M | 0.03% |
1,037,100
-118,400
| -10% | -$3.88M |
|
|
CHS
713
DELISTED
Chicos FAS, Inc.
CHS
| $34M | 0.03% |
8,925,000
+509,700
| +6% | +$1.96M |
|
714
OraSure Technologies
OSUR
$277M
| $33.6M | 0.03% |
4,189,813
-426,290
| -9% | -$3.45M |
|
715
Restaurant Brands International
QSR
$26.7B
| $33.6M | 0.03% |
526,997
+520,997
| +8,683% | +$34.9M |
|
|
UBA
716
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $33.5M | 0.03% |
1,349,007
+97,900
| +8% | +$2.35M |
|
717
Bunge Global
BG
$21.7B
| $33.4M | 0.03% |
580,900
-26,400
| -4% | -$1.46M |
|
|
ATCO
718
DELISTED
Atlas Corp.
ATCO
| $33.4M | 0.03% |
2,347,807
+421,707
| +22% | +$5.03M |
|
719
Lattice Semiconductor
LSCC
$18.2B
| $33.4M | 0.03% |
1,742,500
-942,000
| -35% | -$18.1M |
|
|
SASR
720
DELISTED
Sandy Spring Bancorp Inc
SASR
| $33.3M | 0.03% |
880,041
-179,537
| -17% | -$6.33M |
|
721
Rithm Capital
RITM
$5.79B
| $33.2M | 0.03% |
+2,061,444
| New | +$32.4M |
|
|
IBA
722
DELISTED
Industrias Bachoco SAB De C.V.
IBA
| $33.2M | 0.03% |
638,100
+2,600
| +0.4% | +$134K |
|
|
DOOR
723
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $33.2M | 0.03% |
459,400
+139,300
| +44% | +$9.16M |
|
|
TGI
724
DELISTED
Triumph Group
TGI
| $33.1M | 0.03% |
1,311,800
-105,800
| -7% | -$2.63M |
|
725
Mercantile Bank Corp
MBWM
$1.06B
| $33.1M | 0.03% |
908,613
+80,098
| +10% | +$2.82M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.